Hydrogel Microsphere Based Delivery of Panax quinquefolius L. for Targeted Gut Microbiome Modulation with Design Strategies, Mechanistic Insights, and Therapeutic Prospects
DOI:
https://doi.org/10.62752/ijphi.v3i2.275Keywords:
Panax quinquefolius L.; American ginseng; gut microbiota; ginsenosides; hydrogel microspheres; colon-targeted delivery; microbiome modulation; controlled drug delivery; phytochemicalsAbstract
The gut microbiota is essential for modulating host metabolism, immune responses, intestinal barrier function, and overall health. Dysbiosis of the gut microbial ecosystem has been associated with various chronic diseases, such as inflammatory bowel disease, metabolic disorders, diabetes, cancer, and neuroinflammatory diseases. The biologically active constituents of Panax quinquefoliusL. (American ginseng), mainly ginsenosides and polysaccharides, may interact with the gut microbiota and may be biotransformed by microbes to potentially bioactive metabolites. However, poor stability, variable gastrointestinal metabolism, and inconsistent oral bioavailability may limit the therapeutic application of these phytoconstituents. Microspheres are a promising platform for drug delivery that can protect sensitive phytochemicals and enable controlled, site-specific, and stimuli-responsive release in the gastrointestinal tract. This review highlights the pharmacological relevance of Panax quinquefolius, interactions with the gut microbiome, and the potential of hydrogel microspheres for enhanced gastrointestinal and colon-targeted delivery. Emphasis is placed on the selection of polymers, encapsulation techniques, pH-, enzyme-, and microbiome-responsive systems, and the mechanisms of controlled release and hydrogel–microbiome–host interactions. Possible applications include inflammatory bowel disease, gut-brain axis related disorders, immune regulation, cancer, and neuroinflammatory disorders. Current challenges include variability of gut microbiota, standardization of herbal extracts, and scalability of formulation, long-term safety, and limited clinical evidence. To summarize, hydrogel-based delivery of Panax quinquefoliusis a promising research approach for microbiome-targeted therapy; further mechanistic, preclinical, and clinical studies are needed to establish its safety, reproducibility, and therapeutic relevance.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 © IJPHI GLOBAL PUBLISHER PVT. LTD.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the International Journal of Pharmaceutical and Healthcare Innovation (IJPHI) are licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0). Authors retain copyright of their work and grant the journal the right of first publication. The published material may be used, shared, and reproduced for non-commercial purposes with proper attribution.
© IJPHI GLOBAL PUBLISHER PVT. LTD.








